Thus, IL-6 signaling has been linked to tumor aggressiveness, including cancer stem cell phenotypes [5,6,40,41] and EMT phenotypes [42], drug resistance [43], and anoikis resistance, that is, contact-independent survival, which is required for travel through the vascular system [44]. This evidence concerns the gene IL6 and cancer.